{"id":"W4399881223","doi":"10.1200/jco.2024.42.16_suppl.4105","title":"Clinical outcomes from a phase I clinical trial of a novel oncolytic virus VG161 in patients with hepatocellular carcinoma (HCC) refractory after 2 prior lines of therapy including checkpoint inhibitors (CPI).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver Biotech (Canada)","funders":"China Postdoctoral Science Foundation; National Natural Science Foundation of China","keywords":"Medicine; Internal medicine; Hepatocellular carcinoma; Oncolytic virus; Gastroenterology; Adverse effect; Refractory (planetary science); Response Evaluation Criteria in Solid Tumors; Oncology; Cancer; Phases of clinical research; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001768573,0.0006349189,0.0009503695,0.0002034697,0.0002614397,0.0005081299,0.0002952371,0.0005593594,0.001838933],"category_scores_gemma":[0.0008667462,0.0002099838,0.0008137918,0.0002154287,0.000425913,0.0004399262,0.0002849126,0.001231966,0.0003372785],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000637608,"about_ca_system_score_gemma":0.0006883239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004110048,"about_ca_topic_score_gemma":0.0007145712,"domain_scores_codex":[0.9996567,0.0001741003,0.00002614279,0.00004876139,0.00003193245,0.00006238383],"domain_scores_gemma":[0.9991723,0.0001599562,0.0002146104,0.00006915376,0.00004588709,0.0003381091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7637725,0.03728754,0.04428484,0.000809375,0.002095436,0.0004702072,0.0003729007,0.00380313,0.04471825,0.0002361121,0.003875231,0.0982744],"study_design_scores_gemma":[0.2093697,0.710445,0.06691191,0.00005331466,0.00109816,0.0006776546,0.00009579466,0.00173693,0.006007308,0.0002215233,0.00334591,0.00003675084],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971043,0.001036439,0.0002205884,0.0001307153,0.00003228472,0.0004759564,0.0004454355,0.0000121676,0.0005420231],"genre_scores_gemma":[0.9962591,0.0004619672,0.0003183368,0.0001920473,0.00005689725,0.0004557292,0.001622358,0.000005197842,0.0006283725],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001838933,"threshold_uncertainty_score":0.00935322,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1666419096663506,"score_gpt":0.4833662554161306,"score_spread":0.31672434574978,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}